secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001823239-23-000020
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Maravai LifeSciences COO Brian Neel Resigns; Andrew Burch Named Successor
-------------------------------------------------------------------------

- Brian Neel resigned as COO, Nucleic Acid Production, effective March 31, 2023.
- Andrew Burch, formerly of Thermo Fisher Scientific, appointed EVP and General Manager of Nucleic Acid Products Division.
- Burch will assume his role after Neel's departure on March 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323923000020/0001823239-23-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323923000020/mrvi-20230308.htm
  HTML page:      https://secwatch.observer/filing/0001823239-23-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer